Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

Yasoo Sugiura,1 Etsuo Nemoto,1 Osamu Kawai,2 Yasuyuki Ohkubo,2 Hisae Fusegawa,2 Shizuka Kaseda1 1Department of Pulmonary and Thoracic Surgery, 2Department of Respiratory Medicine, Kanagawa National Hospital, Hadano, Japan Background: Gefitinib is known as one of the agents for treating patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sugiura Y, Nemoto E, Kawai O, Ohkubo Y, Fusegawa H, Kaseda S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/78374b2549a942babf80989947c6b5ba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!